The bovine dilated cardiomyopathy locus maps to a 1.0-Mb interval on chromosome 18 by Owczarek-Lipska, Marta et al.
The bovine dilated cardiomyopathy locus maps to a 1.0-Mb
interval on chromosome 18
Marta Owczarek-Lipska Æ Catherine Denis Æ
Andre´ Eggen Æ Tosso Leeb Æ Horst Posthaus Æ
Gaudenz Dolf Æ Martin H. Braunschweig
Received: 12 November 2008 / Accepted: 30 December 2008 / Published online: 14 February 2009
 Springer Science+Business Media, LLC 2009
Abstract Cardiomyopathies are myocardial diseases that
lead to cardiac dysfunction, heart failure, arrhythmia, and
sudden death. In human medicine, cardiomyopathies fre-
quently warrant heart transplantation in children and adults.
Bovine dilated cardiomyopathy (BDCMP) is a heart mus-
cle disorder that has been observed during the last 30 years
in cattle of Holstein-Friesian origin. In Switzerland
BDCMP affects Swiss Fleckvieh and Red Holstein breeds.
BDCMP is characterized by a cardiac enlargement with
ventricular remodeling and chamber dilatation. The com-
mon symptoms in affected animals are subacute
subcutaneous edema, congestion of the jugular veins, and
tachycardia with gallop rhythm. A cardiomegaly with
dilatation and hypertrophy of all heart chambers, myocar-
dial degeneration, and fibrosis are typical postmortem
findings. It was shown that all BDCMP cases reported
worldwide traced back to a red factor-carrying Holstein-
Friesian bull, ABC Reflection Sovereign. An autosomal
recessive mode of inheritance was proposed for BDCMP.
Recently, the disease locus was mapped to a 6.7-Mb
interval MSBDCMP06-BMS2785 on bovine Chr 18
(BTA18). In the present study the BDCMP locus was fine
mapped by using a combined strategy of homozygosity
mapping and association study. A BAC contig of 2.9 Mb
encompassing the crucial interval was constructed to
establish the correct marker order on BTA18. We show that
the disease locus is located in a gene-rich interval of
1.0 Mb and is flanked by the microsatellite markers
DIK3006 and MSBDCMP51.
Introduction
Cardiomyopathies are diseases of the myocardium associ-
ated with cardiac dysfunction. In human medicine they are
classified as dilated cardiomyopathy, hypertrophic cardio-
myopathy, restrictive cardiomyopathy, and arrhythmogenic
right ventricular cardiomyopathy (Richardson et al. 1996).
Many conditions characteristic for one form of a cardiomy-
opathy may progress to another condition. Cardiomyopathy
frequently results in heart failure, arrhythmia, and sudden
death. The histologic findings in such a dysfunctional myo-
cardium are nonspecific, with hypertrophic myocytes,
cellular necrosis, and fibrosis.
Bovine dilated cardiomyopathy (BDCMP) is a primary
disease of the heart muscle observed worldwide in Hol-
stein-Friesian cattle during the last 30 years. In Switzerland
the introduction of Red Holstein genetics into the Sim-
mental population began in 1968. These crosses are
referred to as Fleckvieh and form a section apart from
Simmental and Red Holstein. BDCMP affects Fleckvieh
and Red Holstein cattle but not the Simmental cattle of the
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Swiss Fleckvieh breed (Graber and Martig 1993; Martig
1992; Martig et al. 1982). The disease is characterized by a
global cardiac enlargement and ventricular remodeling
leading to a chamber dilatation with decreased wall
thickness and a diminution in systolic function. A subacute
subcutaneous edema within the brisket and to a lesser
extent in the mandibular and the ventral abdominal region
is usually observed. Moreover, an increased pulse rate, up
to 140 beats/min, tachycardia with gallop rhythm of the
heart, and congestion of the jugular veins are common in
affected animals. The typical age at onset of BDCMP is
between 2 and 4 years but BDCMP was also diagnosed in
calves younger than 2 months and in cows older than
8 years (Graber and Martig 1993; Martig 1992; Martig and
Reusser 1988). Although BDCMP is a slowly progressive
terminal disease, distinct clinical symptoms develop within
a few days or weeks and all affected animals die or have to
be culled shortly after disease onset (Bradley et al. 1991;
Danzl 1995; Ku¨mper and Bahnemann 1992; Martig and
Tschudi 1985; Martig et al. 1982; McLennan and Kelly
1990; Sonoda et al. 1982; Tontis et al. 1990). Initially,
cardiomyocyte necrosis in all parts of the heart followed by
transmural fibrosis often occurs (Ko¨nig et al. 1990). First,
the left ventricle fails to compensate, leading to pulmonary
hypertension, followed by hypertrophy of the right ventri-
cle, which finally causes the clinically manifest right heart
failure (Lobsiger et al. 1985; Martig and Tschudi 1985).
BDCMP can be easily misdiagnosed as traumatic pericar-
ditis or valvular endocarditis (Martig et al. 1982). The
pathologic findings are cardiomegaly with an extensive
dilatation and hypertrophy of all sections of the myocar-
dium, as well as myocardial fibrosis, partially accompanied
by myofibrillar degeneration. To date, there is no treatment
known for BDCMP.
All reported cases in Canada (Baird et al. 1986), Japan
(Satoh 1988), and Switzerland (Martig and Reusser 1988;
Martig et al. 1982) were traced back to a red factor-car-
rying Holstein–Friesian bull, ABC Reflection Sovereign,
which strongly suggests a hereditary nature of the disease.
A segregation analysis based on an experimental BDCMP
pedigree confirmed the genetic basis of an autosomal
recessive mode of inheritance for the disease (Dolf et al.
1998). Recently, BDCMP cases were reported in Denmark
(Leifsson and Agerholm 2004). BDCMP is periodically
diagnosed in slaughterhouses in Switzerland, but the fre-
quency of the mutant allele responsible for the disease
remains unknown.
The locus for bovine dilated cardiomyopathy was mapped
to Chr 18 (BTA18) in the MSBDCMP06–BMS2785 interval
(Guziewicz et al. 2007). In present study we fine-mapped the
BDCMP locus to a 1.0-Mb interval by a combined homo-
zygosity mapping and association-based strategy.
Material and methods
BAC libraries
Two bovine BAC libraries were explored to establish a BAC
contig around the BDCMP locus on BTA18 (CHORI-240:
bovine BAC library, Children’s Hospital Oakland Research
Institute, USA and the INRA bovine BAC library) Eggen
et al. 2001). CHORI BAC clones were selected based on the
contig information of BTA18 which was released together
with the bovine genome assembly Btau 3.1 (http://www.
hgsc.bcm.tmc.edu/projects/bovine/). The INRA BAC
library was PCR-screened to identify the corresponding
BAC clones. In addition, we used the web-based BAC contig
information tool (http://genome.jouy.inra.fr/WebAGCoL/
CarteBovinGenet/WebFPC/).
DNA extraction from BAC clones
BAC DNA was isolated according to the rapid alkaline
lysis miniprep method developed by the Children’s Hos-
pital Oakland Research Institute (http://bacpac.chori.org/
bacpacmini.htm).
BAC clones screening
BAC DNA from clones of the CHORI BAC library was
tested by PCR. BAC DNA pools from the INRA BAC
library were first PCR-screened and subsequently positive
clones were examined by PCR-based strategy for the
presence of specific markers and genes. The PCR ampli-
fication mixture contained 1.5 ll of BAC DNA (25 ng),
0.4 ll of the primer (10 pmol/ll, forward and reverse,
respectively), 0.2 ll of dNTPs mix (5 mM), 1 ll of
10 9 PCR buffer, and 0.05 ll of AmpliTaqGold poly-
merase (5 U/ll), and deionized water was added to a final
volume of 10 ll (Applied Biosystems, Rotkreuz, Swit-
zerland). The amplification was performed with an initial
denaturation step at 95C for 20 min, followed by 30
cycles with a denaturation step at 94C for 30 sec, an
annealing step at 60C for 1 min, an extension step at
72C for 2 min, and a final extension phase at 72C for
10 min.
The amplicons were separated on 1% agarose gels,
stained with ethidium bromide, and visualized under UV
light. Primer pairs were designed with the PRIMER3
software and are listed in Supplementary Table 1.
To screen BAC clones, 20 microsatellite markers, 7
PCR products with known location on BTA18, and 27 PCR
products of orthologous genes located on human counter-
part Chr 19 (HSA19) were used.
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DNA extraction
DNA from 49 blood samples was isolated using Chelex
100 (BioRad, Reinach BL, Switzerland) or a High Pure
PCR Template Purification Kit (Roche Diagnostics, Rotk-
reuz, Switzerland). DNA from 304 formalin-fixed and
thereafter paraffin-embedded myocardial samples from
BDCMP-affected animals was isolated and purified using a
DNeasy Blood & Tissue Kit (Qiagen, Hombrechtikon,
Switzerland).
Genotyping with microsatellite markers
In the present study, samples from 353 animals were
genotyped for 24 microsatellite markers (MS) in the
interval between MSBDCMP06 and BMS2785, whereof 9
were selected from publically available data and 15 rep-
resent newly developed markers taken from the bovine
genome sequence assembly Btau 4.0 (Supplementary
Table 2).
The volume of a multiplex amplification reaction was
10 ll and contained 2 ll of DNA (20 ng), 0.2 ll of each
primer (10 pmol/ll, forward and reverse, respectively),
5 ll of Multiplex PCR Master Mix (Qiagen), and 1 ll of
5 9 Q-solution. Water was added to reach the final vol-
ume. Most of the multiplex reactions contained a
combination of five different primer pairs. The PCR was
conducted under the following conditions: initial denatur-
ation step at 95C for 15 min, 30 cycles with a denaturation
step at 94C for 30 sec, an annealing step at 60C for
1 min, and an extension step at 72C for 45 sec. The final
extension step was carried out for 30 min at 60C. PCR
products were initially examined on 2% agarose gels and,
subsequently, 1 ll of each PCR was combined with 10 ll
of genotyping mix (980 ll of HiDi formamide and 20 ll of
GeneScanTM-500 LIZTM Size Standard, Applied Biosys-
tems). After a 2-min denaturation at 95C and chilling on
ice, samples were genotyped on an ABI 3730 capillary
sequencer (Applied Biosystems). The data were processed
using the GeneMapper software ver. 4.0 (Applied
Biosystems).
SNP genotyping
Annotated SNPs (http://www.ncbi.nlm.nih.gov/sites/entrez?
db=snp) were selected according to their location within the
interval of interest on BTA18. Additional SNP markers were
developed in order to increase the marker density in the
critical interval. These SNPs in the 1.0-Mb region between
microsatellites markers DIK3006 and MSBDCMP51 flanked
by the distal genes APOE and NPAS1 were genotyped using a
panel of 18 BDCMP-affected animals and 18 controls. In
total, 38 PCR products were obtained according to standard
protocols (Supplementary Table 3). These 38 PCR products
each contained one to eight SNPs resulting in a total of 123
SNPs. Amplicons were purified with rAPid alkaline phos-
phatase (Roche) and exounuclease I (N.E.B., Bioconcept,
Allschwil, Switzerland). Both strands were directly
sequenced on an ABI 3730 capillary sequencer (Applied
Biosystem) using the BigDye Terminator Cycling Kit
(Applied Biosystems). Sequencing data were analyzed using
the Sequencher 4.8 software (Gene Codes Corporation, Ann
Arbor, MI, USA).
Statistical analysis
The statistical analysis including genotypes of 123 SNP
markers was initially performed with SAS Genetics 9.1.3
software (SAS Institute Inc., Cary, NC, USA) using the
procedure allele. The established minor allele frequency
(MAF) was 20%. In total, 86 SNP markers were analyzed
with the SAS Genetics 9.1.3 software procedure casecontrol
and with the Haploview 4.0 software (Barrett et al. 2005)
(http://www.broad.mit.edu/mpg/haploview/download.php).
A permutation test was carried out with 1000 permutations
and the single marker procedure was selected.
Results and discussion
BAC contig construction
The comparison between the cattle and the human maps
revealed that the critical region on bovine Chr 18
(BTA18q) is homologous to human Chr 19 (HAS19)
(Guziewicz 2004). Recently, Guziewicz et al. (2007)
demonstrated in an experimental pedigree segregating for
BDCMP that the disease locus maps to a 6.7-Mb region
encompassed by MS markers MSBDCMP06 and BMS2785
on BTA18 (Btau 3.1). This interval corresponds now to
5.6 Mb in the bovine genome sequence assembly Btau 4.0.
The publicly available BAC contig listing of bovine
CHORI BACs was initially used to build the contig around
the BDCMP locus. Although the information of the over-
lapping genomic sequence was indicated in the BAC contig
provided by the bovine genome project, several overlaps
could not be verified by PCR-based STS content mapping.
Therefore, additional BAC clones were introduced from
the INRA bovine BAC library in the attempt to close the
remaining gaps. The combination of clones from the two
BAC libraries allowed us to construct a 2.9-Mb BAC
contig spanning the interval between MS markers
MSBDCMP22 and BMS2785 (Fig. 1b). The minimal tiling
path of this contig consists of 23 tiled BAC clones. We
found that the gene order on a chromosomal segment
M. Owczarek-Lipska et al.: BDCMP maps to a 1.0-Mb interval on Chr 18 189
123
between positions 51.11 and 52.12 Mb was inverted in
Btau 3.1 as compared to our BAC contig and the human
counterpart HSA19. This finding was then fully confirmed
in the recent cattle genome assembly (Btau 4.0), where the
gene order in the critical interval is in agreement with that
in our BAC contig and human Chr 19. The BAC contig is
an excellent tool toward fine mapping the critical interval,
to map the DNA markers, and to explore the still existing
and numerous DNA sequence gaps in the present version of
the bovine genome.
Homozygosity mapping of the BDCMP locus
This approach aims to identify the autosomal recessive
disease-causing locus by virtue of the fact that the adjacent
DNA sequence is homozygous by descent. It is evident that
all BDCMP-affected animals in the Swiss Fleckvieh pop-
ulation trace back to the Canadian bull ABC Reflection
Sovereign (Dolf et al. 1998). Therefore, alleles adjacent to
the BDCMP locus are considered identical by descent and
share extended haplotypes. In an initial step 25 BDCMP-
affected and 24 unaffected Fleckvieh animals were geno-
typed with nine MS markers randomly distributed within
the interval between MS markers MSBDCMP06 and
BMS2785, previously defined by Guziewicz et al. (2007).
All the affected animals were homozygous at the markers
MSBDCMP22, DIK3006, DIK3014, MSBDCMP25, and
RME01 supporting the hypothesized identity by descent.
Chromosomes were considered recombinant for an indi-
vidual that is heterozygous for markers located distal of the
interval MSBDCMP06–BMS2785 and homozygous for
adjacent markers located within this interval. We found 11
presumably recombinant chromosomes on the centromeric
site and 9 on the telomeric site of the interval
MSBDCMP06–BMS2785. This homozygosity mapping
narrowed the critical interval down to about 4.1 Mb
between markers MSBDCMP06 and MSBDCMP51. An
additional 15 evenly distributed MS markers were selected
within the interval MSBDCMP06–BMS2785 based on the
bovine genome sequence assembly Btau 4.0. The markers
were chosen so that they were evenly distributed in the
interval. DNA from 304 paraffin-embedded heart tissue
samples of cattle with a positive BDCMP diagnosis,
including some cases with uncertain diagnoses, were
available for genotyping. The advantage of these paraffin-
embedded samples is that the BDCMP diagnosis can be
reevaluated based on histologic criteria by an experienced
pathologist. Furthermore, these paraffin-embedded samples
were collected during a period of about 20 years at two
different locations in Switzerland and the BDCMP animals
were originally diagnosed by different pathologists. The
reevaluation is important as BDCMP can be easily mis-
diagnosed. We genotyped all these samples with 24 MS
markers in the interval MSBDCMP06–BMS2785. The
identification of an additional 3 and 18 recombinant chro-
mosomes from the centromeric and telomeric side,
respectively, allowed us to reduce the critical interval from
4.1 to 1.0 Mb. The current 1.0-Mb interval is flanked by
MS markers DIK3006 and MSBDCMP51 (Fig. 1a). It is
striking that the BDCMP-affected animals, previously
assumed to be unrelated, are all homozygous for the
markers that were also homozygous in the BDCMP ani-
mals in the experimental pedigree. This finding strongly
indicates that indeed all affected animals are descendents
from a single founder animal.
Association study
In this study we combined homozygosity mapping with an
association-based strategy to further fine map the BDCMP
locus in the interval between MS DIK3006 and
MSBDCMP51 (Fig. 1a). We included on each distal site of
this interval additional SNP markers located in APOE and
NPAS1 genes, respectively. The association study was
performed including these markers and indicates that the
region outside of DIK3006 and MSBDCMP51 is not
associated with BDCMP. In this interval a total of 36 PCR
products containing one to eight SNP markers were gen-
otyped by means of DNA sequencing for 18 BDCMP-
affected and 18 unaffected animals. In addition, two fam-
ilies comprising eight individuals from the experimental
pedigree were included in the genotyping procedure to
deduce the disease haplotype. BAC clones were tested by
PCR to map the SNP markers to our BAC contig. However,
one of these PCR products containing six SNPs (Supple-
mentary Table 3) was thereafter excluded from the
association study because we could not amplify it on any of
the BAC clones. This emphasizes that the BAC contig can
be a useful tool in the fine mapping of disease genes.
The association study was initially performed using SAS
Genetics software. A minimal MAF of 20% was applied in
the analysis resulting in the exclusion of 31 SNP markers.
The SNP in NPAS1 gene was therefore excluded from the
final analysis and is not presented in Fig. 1c. The geno-
types of 86 remaining SNP markers were thereafter
analyzed using the Haploview 4.0 software. The best
observed v2 was 60.4 and the best permutation v2 (1000
permutations, single marker) was 21.4. The analyses
revealed significant association between markers and dis-
ease over the whole interval DIK3006-MSBDCMP51 and
showed three highly associated regions (Fig. 1c).
The human HSA19 counterpart of this 1.0-Mb interval
corresponds to a region between 50.50 and 52.11 Mb
(Build 36.6). This is a gene-rich region and contains 47
genes and 18 annotated hypothetical loci. In the mouse this
region was found on Chr 7 (MMU7) between 17.07 and
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19.99 Mb (Build 37.1) but the gene order is inverted
compared to that in human and cattle.
An in silico evaluation showed that among 47 genes on
HSA19, CKM, VASP, PPP1R13L, DMPK, and AP2S1
genes are highly expressed in the cardiovascular system;
moderately expressed are the GIPR, PNMAL2, and GRLF1
genes, and GPR4, IGFL3, HIF3A, PRKD2, STRN4, and
FKRP are reported to be expressed in the heart (http://
www.dsi.univ-paris5.fr/genatlas/, http://www.ncbi.nlm.nih.
gov/). An association between two of these genes, the
fukutin-related protein gene (FKRP) and the vasodilator-
stimulated phosphoprotein gene (VASP), and dilated car-
diomyopathy was reported. Mu¨ller et al. (2005) found
evidence that dilated cardiomyopathy in human may be
associated with a C826A mutation in the FKRP gene.
Although mutations in this gene are mostly responsible for
limb-girdle muscular dystrophy (LGMD2I), they described
three siblings showing the C826A substitution and an
unusual phenotype with dilated cardiomyopathy and
without changes in skeletal muscles. Our preliminary
results indicate that there are no differences in the FKRP
sequence between BDCMP-affected and unaffected ani-
mals. Eigenthaler et al. (2003) described that a disruption
of cardiac Ena-VASP protein in mice may play a crucial
role in intercalated disk function at the interface between
cardiac myocytes and thereby might cause dilated cardio-
myopathy. However, to our knowledge no mutation in the
VASP gene in any species has yet been reported to be
associated with cardiomyopathy.
In conclusion, using the combined strategy of homozy-
gosity mapping and association study, we were able to fine
map the BDCMP locus to a region of about 1.0 Mb. At
Fig. 1 Genetic mapping of the BDCMP locus. a Initial interval
defined to 6.7 Mb between MS markers MSBDCMP06 and BMS2785
based on Btau 3.1 corresponds to a physical distance of 5.6 Mb on
Btau 4.0. Current interval of 1.0 Mb is flanked by MS markers
DIK3006 and MSBDCMP51. The association study was performed in
the 1.0-Mb interval surrounded by the distal genes APOE and NPAS1.
b BAC contig of 2.9 Mb between MS markers MSBDCMP22 and
BMS2785 composed of 23 BAC clones. Open circles, filled circles,
and open squares indicate MS markers, genes, and PCR products with
known location on BTA18, respectively. c Schematic presentation of
the association analysis (Haploview 4.0 software). The best observed
v2 was 60.44. The dashed line indicates the significance threshold
obtained by permutation testing (best permutation v2 was 21.45, 1000
permutations). v2 values are plotted against the physical distance on
BTA18. In total, 86 SNP markers with MAF above 20% were
analyzed
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present we are screening recombinant animals with addi-
tional SNP markers to further narrow down the interval. In
addition, we will further investigate those genes that are
expressed in the cardiovascular system. It is still possible
that genes with not yet known function as well as regula-
tory mutations or chromosomal rearrangements may play
an important role in the development of BDCMP.
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